ADDENDUM TO LETTER AGREEMENTLetter Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis ADDENDUM TO LETTER AGREEMENT (the "Addendum") is entered into as of December 28, 2004 (the "Effective Date") by and between Milan Mandaric ("Mandaric") and NatureWell, Incorporated (the "Company") with reference to the following:
LETTER AGREEMENTLetter Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis LETTER AGREEMENT (the "Agreement") is entered into by and between NatureWell, Incorporated (the "Company") and Timothy R. Scott ("Scott") and is made effective as of February 21, 2005 (the "Effective Date"). The Company and Scott agree as follows:
GUARANTY AGREEMENTGuaranty Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 22nd, 2005 Company Industry JurisdictionMilan Mandaric ("Guarantor") and NatureWell, Incorporated (the "Company") hereby enter into this Guaranty Agreement (the "Guaranty" or "Mandaric Guaranty") as of December 28, 2004 (the "Effective Date") for the express benefit of any party that holds an Investor Note (defined below) issued by the Company.
LETTER AGREEMENTConvertible Note Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis LETTER AGREEMENT (the "Agreement") is entered into by and between NatureWell, Incorporated (the "Company") and Robert T. Malasek ("Malasek") and is made effective as of February 21, 2005 (the "Effective Date"). The Company and Malasek agree as follows:
LETTER AGREEMENTLetter Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis LETTER AGREEMENT (the "Agreement") is entered into by and between NatureWell, Incorporated (the "Company") and John W. Huemoeller ("Huemoeller") and is made effective as of February 21, 2005 (the "Effective Date"). The Company and Huemoeller agree as follows:
LETTER AGREEMENTLetter Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis LETTER AGREEMENT (the "Agreement") is entered into by and between NatureWell, Incorporated (the "Company") and James R. Arabia ("Arabia") and is made effective as of February 21, 2005 (the "Effective Date"). The Company and Arabia agree as follows:
LETTER AGREEMENTConvertible Note Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 22nd, 2005 Company IndustryThis LETTER AGREEMENT (the "Agreement") is entered into by and between NatureWell, Incorporated (the "Company") and Donald Brucker ("Brucker") and is made effective as of February 21, 2005 (the "Effective Date"). The Company and Brucker agree as follows:
LETTER AGREEMENTGuaranty Agreement • February 22nd, 2005 • Naturewell Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledFebruary 22nd, 2005 Company Industry JurisdictionThis Letter Agreement (the "Agreement") is entered into as of December 28, 2004 (the "Effective Date") by and between Milan Mandaric ("Mandaric") and NatureWell, Incorporated (the "Company") with reference to the following facts: